Peanut Patch Receives FDA’s Breakthrough Therapy Designation

The Viaskin Peanut patch received the BT designation after a positive Phase IIb trial.

FDA Provides Primer on Current State of Allergy Immunotherapies

We provide a summary for individuals new to the world of food allergies and therapies under investigation.

Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis

The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.
Pills

Auto-Injector? No… Epinephrine in a Tablet!

A researcher from Nova Southeastern University is working on a novel way to deliver epinephrine.

Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the AAAAI Conference

We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II

The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.

Delivering the Next Generation Auto-Injector

CEO Christopher Stepanian tells us how Windgap's auto-injector seeks to 'improve the quality of life for patients living with severe allergies.'

Company Seeks to Remove the Allergist from Treating Food Allergy

AllergyEasy manufactures dropsĀ used in sublingual immunotherapy, not approved by the FDA for the treatment of food allergy.

Patent Issued for Innovative Auto-Injector Mechanism

Does this portend an auto-injector with a longer shelf-life, impervious to temperature changes, and the size of a USB thumb-drive that could be carried on a key chain?
Afrezza Inhalable Insulin Device

Pharmaceutical Company Developing Inhalable Epinephrine

MannKind Corporation is developing a product that would dispose of the needle entirely.

Connect with Us

28,711FansLike
86FollowersFollow
4,048FollowersFollow
31SubscribersSubscribe